Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Livalo(calcium salt),zypitamag(magnesium salt)
Synonyms :
Class :
Lipid-lowering agents, statins:HMG Co-A reductase inhibitors
Brand Name :
Livalo(calcium salt),zypitamag(magnesium salt)
Synonyms :
Class :
Lipid-lowering agents, statins:HMG Co-A reductase inhibitors
Dosage Forms & StrengthsÂ
Tablet:Â
1mg,2mg,4mgÂ
Initial dose:
2
mg
Tablet
Orally 
once a day
Maximum dose-4mg orally every day
Initial dose:
2
mg
Tablet
Orally 
once a day
Maximum dose-4mg orally every day
Dose Adjustments
Dosage adjustment
Renal impairment: eGfr-15 to 59 ml/min/1.73m2
Initial dose-1mg orally once a day
Maximum dose-2mg orally once a day
Dosage Forms & StrengthsÂ
Tablet:Â
1mg,2mg,4mgÂ
Heterozygous Familial Hypercholesterolemia
<8 years: safety and efficacy not established
>8 years: initial dose-2mg orally every day
Maintenance dose-4mg orally every day
may increase the toxicity of each other
may increase the toxicity of each other
may increase the toxicity of each other
may increase the level of each other by unknown mechanism
may increase the toxicity of each other
may increase the toxicity of each other
may increase the toxicity of each other
may diminish the serum concentration when combined with tenapanor
may increase the toxic effects of antibiotics
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may increase the toxicity of each other
may enhance the level of each other when combined
May enhances the effects of the other by pharmacodynamic synergism
it may increase the toxicity of each other
may enhance the level of each other when combined
May enhances the effects of the other by pharmacodynamic synergism
it may increase the toxicity of each other
may enhance the serum concentration of each other when combined
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
it may increase the toxicity of each other
It may enhance toxicity when combined with cholic acid by diminishing the elimination
It may enhance the effect when combined with tafamidis meglumine
When pitavastatin is used together with ouabain, this leads to reduction in pitavastatin excretion
when both drugs are combined, there may be a decreased excretion rate of pitavastatin  
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
It may enhance the risk of adverse effects when combined with antihyperlipidemic
It may enhance the risk of adverse effects when combined with antihyperlipidemic
It may enhance the risk of adverse effects when combined with antihyperlipidemic
the rate of excretion of pitavastatin may be reduced
ciprofibrate: it may enhance the serum concentration of HMG-CoA Reductase Inhibitors
may increase the level of each other by unknown mechanism
May enhances the effects of the other by pharmacodynamic synergism
may increase the level of each other by unknown mechanism
Frequency defined:Â Â Â
1-10%Â
Back pain (1.4-3.9%)Â
Constipation (1.5-3.6%)Â
Diarrhea (1.5-2.6%)Â
Myalgia (1.9-3.1%)Â
Pain in extremities (0.6-2.3%)Â Â
Post-marketing reportsÂ
DyspepsiaÂ
HepatitisÂ
Peripheral neuropathyÂ
MyopathyÂ
Erectile dysfunctionÂ
Interstitial lung diseaseÂ
Pregnancy consideration: The safety of the drug is not established during pregnancy Â
Lactation: The excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Â
Patient information leafletÂ
Generic Name:pitavastatinÂ
Pronounced: [ pit-AV-a-STAT-in] Â
Why do we use pitavastatin?Â
Pitavastatin is used to lower blood cholesterol levels which helps in preventing heart attacks.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
